Kaitai Capital is a Hangzhou-based venture capital firm investing across China and the United States, with a focus on early-stage innovation and activity from seed through later-stage venture rounds. The firm backs companies in life sciences, biotechnology, pharmaceuticals and oncology, alongside artificial intelligence, big data, enterprise software and information technology.